Cancer cell genotype associated tumor immune microenvironment exhibits differential response to therapeutic STING pathway activation in high-grade serous ovarian cancer

BACKGROUND: High-grade serous ovarian carcinoma (HGSC) is the most lethal gynecologic malignancy characterized by resistance to chemotherapy and high rates of recurrence. HGSC tumors display a high prevalence of tumor suppressor gene loss. Given the type 1 interferon regulatory function of BRCA1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakfa, Noor, Li, Deyang, Conseil, Gwenaelle, Lightbody, Elizabeth D, Wilson-Sanchez, Juliette, Hamade, Ali, Chenard, Stephen, Jawa, Natasha A., Laight, Brian J., Afriyie-Asante, Afrakoma, Tyryshkin, Kathrin, Koebel, Martin, Koti, Madhuri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083863/
https://www.ncbi.nlm.nih.gov/pubmed/37015760
http://dx.doi.org/10.1136/jitc-2022-006170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083863/
https://www.ncbi.nlm.nih.gov/pubmed/37015760
http://dx.doi.org/10.1136/jitc-2022-006170

Ejemplares similares